https://biotechmorning.com/news/zorevunersen-dravet-syndrome-4-year-data Biotech Morning en 2026-09-04T14:18:33.667Z The Drug That Might Actually Rewire a Child's Brain https://biotechmorning.com/news/pfizer-sells-seagen-adc-12-million-medicus Biotech Morning en 2026-09-04T14:17:44.697Z Pfizer Just Sold a Cancer Drug for the Price of a Nice House https://biotechmorning.com/news/fda-tempo-pilot-ai-devices-before-authorization Biotech Morning en 2026-09-04T14:17:00.054Z The FDA Just Let AI Doctors See Patients Without a License https://biotechmorning.com/news/ivonescimab-beats-keytruda-overall-survival-lung-cancer Biotech Morning en 2026-09-04T14:16:11.246Z The Cancer Drug That Just Beat the World's Best-Selling Medicine https://biotechmorning.com/news/alexander-disease-first-treatment-zanvastro Biotech Morning en 2026-09-04T14:15:22.452Z The Disease That Had Zero Treatments Just Got Its First https://biotechmorning.com/news/abbvie-crashes-myeloma-party-etentamig-phase-3 Biotech Morning en 2026-09-04T14:14:40.845Z AbbVie Crashes the Myeloma Party Three Years Late. Was It Worth the Wait? https://biotechmorning.com/news/roche-ucn2-muscle-sparing-weight-loss Biotech Morning en 2026-09-04T14:13:52.866Z Roche's Secret Weapon for Weight Loss Might Actually Save Your Muscles https://biotechmorning.com/news/keytruda-biosimilar-cipla-qilu-deal Biotech Morning en 2026-09-04T14:13:06.001Z The $32 Billion Drug Just Got a Rival From an Unlikely Tag Team https://biotechmorning.com/news/psilocybin-prevents-chemo-nerve-pain-mice Biotech Morning en 2026-09-04T14:12:18.108Z A Single Dose of Magic Mushrooms Blocked Chemo Pain for 8 Months https://biotechmorning.com/news/kardigan-myokardia-400m-ipo-comeback Biotech Morning en 2026-09-04T14:11:27.337Z The MyoKardia Gang Just Pulled Off a $400M Comeback https://biotechmorning.com/news/novartis-autoimmune-car-t-deaths-pause Biotech Morning en 2026-09-04T14:10:39.781Z The Cancer Therapy That Killed Three People Who Didn't Have Cancer https://biotechmorning.com/news/fda-reversal-uniqure-huntingtons-gene-therapy Biotech Morning en 2026-09-03T14:19:17.216Z The FDA Said No. Then It Said Yes. Now This Gene Therapy Could Change Everything. https://biotechmorning.com/news/gsk-hutchmed-kras-egfr-deal Biotech Morning en 2026-09-03T14:18:26.949Z GSK's $1.3B Bet on a Two-Headed Cancer Killer https://biotechmorning.com/news/novartis-argo-5-billion-cardiovascular-deal Biotech Morning en 2026-09-03T14:17:41.347Z Novartis Just Bet $5.2B on a Chinese Biotech You've Never Heard Of https://biotechmorning.com/news/ivonescimab-beats-keytruda-overall-survival-nsclc Biotech Morning en 2026-09-03T14:16:55.323Z The Drug That Just Beat Keytruda at Its Own Game https://biotechmorning.com/news/arpa-h-benchtop-mrna-manufacturing-waterfall-scientific Biotech Morning en 2026-09-03T14:16:10.330Z The Benchtop Machine That Could Replace an Entire mRNA Factory https://biotechmorning.com/news/fda-china-clinical-trial-scrutiny Biotech Morning en 2026-09-03T14:15:27.751Z The FDA Just Put China's Clinical Trial Pipeline on Notice https://biotechmorning.com/news/crispr-deaths-china-viral-vector-delivery-debate Biotech Morning en 2026-09-03T14:14:46.992Z CRISPR's Body Count Is Growing. The Delivery Truck Is the Problem. https://biotechmorning.com/news/teva-celiac-disease-anti-il15-phase-2-win Biotech Morning en 2026-09-03T14:13:56.450Z The Pill That Could Let Celiac Patients Eat Bread Again https://biotechmorning.com/news/tg4050-cancer-vaccine-zero-relapses-three-years Biotech Morning en 2026-09-03T14:13:09.055Z Zero Relapses in Three Years: The Cancer Vaccine That Won't Blink https://biotechmorning.com/news/ultragenyx-angelman-syndrome-phase-3-failure Biotech Morning en 2026-09-03T14:12:25.348Z The Drug That Was Supposed to Change Angelman Syndrome Just Flopped